S. aureus

More documents

Recommendations

Info

MRSA Screening Program • Intervention: Admission MRSA screening and isolation to assure new admissions we are doing our best so they will not get MRSA from NorthShore – Start with >90% compliance • Admission order set for PCTs and nursing – Admission MRSA Screen – Choice for response either yes or refused • Treatment order package (nasal mupirocin twice daily for 5 days with chlorhexidine bathing) – Type in MRSA, and order MRSA Decolonization Panel LR Peterson et al, Jt Com J Qual Pt Safety, 33:732-8, 2007
NorthShore MRSA Program Began on August 1, 2005 • Observational study in a 3-hospital, 850-bed organization with 40,000 annual admissions comparing rates of MRSA clinical disease during and 30 days after hospital admission • Real-time PCR-based nasal surveillance for MRSA followed by topical decolonization therapy and contact isolation of patients who tested positive for MRSA
Page 1 and 2: The Skin Microbiome - Clinical Labo
Page 3 and 4: Objectives • Review the relevance
Page 5 and 6: Skin Ecology - Dominance • Propio
Page 7 and 8: Microbiome of the Nose • S. aureu
Page 9 and 10: Risk for S. aureus Infection • Sy
Page 11 and 12: Review of Mupirocin Decolonization
Page 13 and 14: CDC Surveillance (2005) • Prospec
Page 15 and 16: US Infection Mortality 2005 FR DeLe
Page 17: Percent Positive on Admission 25.0
Page 21 and 22: Includes all admissions (Community
Page 23 and 24: Medical and Economic Outcome • Ex
Page 25 and 26: Cluster Randomized Trial of ICU: De
Page 28 and 29: Changing Prevalence of S. aureus in
Page 30 and 31: Results of Preoperative Screening f
Page 32 and 33: Prospective, Randomized Trial of S.

S. aureus

Create successful ePaper yourself

Delete template?

Save as template?